Time needed to perform intermittent catheterization in adults with spinal cord injury: A pilot randomized controlled cross-over trial

被引:3
|
作者
Gopalakrishnan, Karthik [1 ,2 ]
Nielsen, Nick Fabrin [3 ]
Ramirez, Andrea L. [1 ]
Sorensen, Jeppe [3 ]
Walter, Matthias [1 ,4 ]
Krassioukov, Andrei, V [1 ,5 ,6 ]
机构
[1] Univ British Columbia, Fac Med, Int Collaborat Repair Discoveries, Vancouver, BC, Canada
[2] Univ Dalhousie, Fac Med, Dept Internal Med, Halifax, NS, Canada
[3] Coloplast AS, Global Market Access, Humlebaek, Denmark
[4] Univ Basel, Univ Hosp Basel, Dept Urol, Basel, Switzerland
[5] Univ British Columbia, Fac Med, Div Phys Med & Rehabil, Vancouver, BC, Canada
[6] GF Strong Rehabil Ctr, Vancouver, BC, Canada
来源
CONTINENCE REPORTS | 2022年 / 2卷
关键词
Hydrophilic catheter; Intermittent catheterization; Non-hydrophilic catheter; Preparation; Satisfaction; Spinal cord injury; Temporal burden; QUALITY-OF-LIFE; COST-EFFECTIVENESS ANALYSIS; SELF-CATHETERIZATION; EXPERIENCES; MANAGEMENT; BARRIERS; BLADDER;
D O I
10.1016/j.contre.2022.100010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Intermittent catheterization (IC), considered the gold standard for bladder management for individuals with spinal cord injury (SCI) with sufficient dexterity, is usually performed using hydrophilic (HPC) or non-hydrophilic catheters (non-HPC). Currently, there is little evidence on the temporal burden associated with IC in general. Our objective was to compare both catheters regarding their time requirement for IC and participant satisfaction. Materials and Methods: Twenty individuals with chronic (>1-year) SCI were randomized to undergo two cross-over assessments within 10 days (i.e., either starting with HPC or non-HPC). We measured the time taken to perform IC using a 13 step pre-determined protocol. Furthermore, we assessed user satisfaction of both catheters using a Likert scale. Time to perform IC and participant satisfaction were compared using non-parametric statistics. Results are presented as median with lower and upper quartiles. Results: Participants using an HPC spent significantly less time overall to perform IC [283 s (242; 352) vs. 373 s (249; 441), p = 0.01] and to prepare a catheter [15 s (10; 20) vs. 41 (20; 69), p = 0.002, i.e. adjusted for multiple comparisons] compared to non-HPC. No significant differences between both catheters were found with respect to participant satisfaction. Conclusions: This crossover RCT revealed that the overall time to perform IC appears to be a significant temporal burden for individuals with SCI independent of the catheter type. Further, we found that the preparation and usage of HPC for IC is faster compared to non-HPC. These findings warrant a larger trial to further assess the temporal burden of IC in this cohort.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] A 16-week randomized controlled trial evaluating the physical activity guidelines for adults with spinal cord injury
    C A Pelletier
    J O Totosy de Zepetnek
    M J MacDonald
    A L Hicks
    Spinal Cord, 2015, 53 : 363 - 367
  • [32] A 16-week randomized controlled trial evaluating the physical activity guidelines for adults with spinal cord injury
    Pelletier, C. A.
    Totosy de Zepetnek, J. O.
    MacDonald, M. J.
    Hicks, A. L.
    SPINAL CORD, 2015, 53 (05) : 363 - 367
  • [33] Intradialytic cardiovascular injury is lowest in high-volume haemodiafiltration: a randomized cross-over trial in four intermittent dialysis strategies
    Liu, Peiyun
    Rootjes, Paul A.
    van Zuijdewijn, Camiel L. M. de Roij
    Hau, Chi M.
    Nube, Menso J.
    Nieuwland, Rienk
    Wijngaarden, Gertrude
    Grooteman, Muriel P. C.
    CLINICAL KIDNEY JOURNAL, 2024, 17 (06)
  • [34] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
    Lopez-Sendon Moreno, Jose Luis
    Garcia Caldentey, Juan
    Trigo Cubillo, Patricia
    Ruiz Romero, Carolina
    Garcia Ribas, Guillermo
    Alonso Arias, M. A. Alonso
    Jesus Garcia de Yebenes, Maria
    Maria Tolon, Rosa
    Galve-Roperh, Ismael
    Sagredo, Onintza
    Valdeolivas, Sara
    Resel, Eva
    Ortega-Gutierrez, Silvia
    Laura Garcia-Bermejo, Maria
    Fernandez Ruiz, Javier
    Guzman, Manuel
    de Yebenes Prous, Justo Garcia
    JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1390 - 1400
  • [35] Intravenous lidocaine relieves spinal cord injury pain - A randomized controlled trial
    Finnerup, NB
    Biering-Sorensen, F
    Johannesen, IL
    Terkelsen, AJ
    Juhl, GI
    Kristensen, AD
    Sindrup, SH
    Bach, FW
    Jensen, TS
    ANESTHESIOLOGY, 2005, 102 (05) : 1023 - 1030
  • [36] Randomized-Controlled Trial of Minocycline for Spinal Cord Injury Shows Promise
    Monaco, Edward A., III
    Weiner, Gregory M.
    Friedlander, Robert M.
    NEUROSURGERY, 2013, 72 (02) : N17 - N19
  • [37] Dialysis-Associated Hypertension Treated with Telmisartan - DiaTel: A Pilot, Placebo-Controlled, Cross-Over, Randomized Trial
    Huber, Matthias
    Treutler, Till
    Martus, Peter
    Kurzidim, Antje
    Kreutz, Reinhold
    Beige, Joachim
    PLOS ONE, 2013, 8 (11):
  • [38] A comparison of inhalation sedation agents in the management of children receiving dental treatment: a randomized, controlled, cross-over pilot trial
    Soldani, Francesca
    Manton, Sarah
    Stirrups, David R.
    Cumming, Craig
    Foley, Jennifer
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2010, 20 (01) : 65 - 75
  • [39] Intermittent Catheterization With a Hydrophilic-Coated Catheter Delays Urinary Tract Infections in Acute Spinal Cord Injury: A Prospective, Randomized, Multicenter Trial
    Cardenas, Diana D.
    Moore, Katherine N.
    Dannels-McClure, Amy
    Scelza, William M.
    Graves, Daniel E.
    Brooks, Monifa
    Busch, Anna Karina
    PM&R, 2011, 3 (05) : 408 - 417
  • [40] Increasing Warmth in Oncological Patients: A Randomized Controlled Cross-Over Pilot Trial Examining the Efficacy of Mustard and Ginger Footbaths
    Vagedes, Jan
    Kuderer, Silja
    Vagedes, Katrin
    Hiller, Stefan
    Beissner, Florian
    Szoke, Henrik
    Joos, Stefanie
    Wolf, Ursula
    INTEGRATIVE CANCER THERAPIES, 2021, 20